In the present study, while CD86 and PD-L1 were expressed at constant levels throughout tumor growth and regression phases, the level of CD80 positive cells was shown to decline during the latter pointing to a CD80 mediated effect on tumor immune evasion in CCH. The gene discussed is CD80; the disease is neoplasm.